| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |